• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非裔美国人终末期肾病的家族风险。

The familial risk of end-stage renal disease in African Americans.

作者信息

Freedman B I, Spray B J, Tuttle A B, Buckalew V M

机构信息

Department of Medicine, Bowman Gray School of Medicine of Wake Forest University, Winston-Salem, NC 27157-1053.

出版信息

Am J Kidney Dis. 1993 Apr;21(4):387-93. doi: 10.1016/s0272-6386(12)80266-6.

DOI:10.1016/s0272-6386(12)80266-6
PMID:8465818
Abstract

African Americans have higher overall incidence rates of end-stage renal disease (ESRD) compared with American whites. Hypertensive nephrosclerosis (HN), nephropathy secondary to diabetes mellitus types I and II, and chronic glomerulonephritis (CGN) all occur more frequently in African Americans. To explore the possibility that hereditary factors may play a role in the increased risk of ESRD in African Americans, the family history of 131 African American hemodialysis patients (cases) was compared with 115 age-, sex-, and race-matched non-ESRD controls. Odds ratios (ORs) were calculated to define the prevalence of a relative with ESRD among cases versus controls. Chi-square values were estimated from a log-linear model, while controlling for gender, to test for significance of ORs. Forty percent (12/30) of HN cases, 35% (18/51) of type II diabetes mellitus-induced renal failure cases, and 13% (5/38) of CGN cases had a first-, second-, or third-degree relative with ESRD. The presence of a first-degree relative with ESRD increased an African American's risk for developing ESRD ninefold (OR, 9.13; 95% confidence interval [CI], 2.6 to 31.8; P < 0.001). The presence of a first- or second-degree relative increased the risk fivefold (OR, 5.23; 95% CI, 2.2 to 12.3; P < 0.0002). First-, second-, or third-degree relatives with ESRD were more prevalent among cases with ESRD due to hypertension and type II diabetes mellitus compared with CGN (P < or = 0.05). Gender differences among the ORs were nonsignificant (P > 0.2) and socioeconomic class (level of education and income) did not differ markedly between cases and controls.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

与美国白人相比,非裔美国人终末期肾病(ESRD)的总体发病率更高。高血压性肾硬化(HN)、I型和II型糖尿病继发的肾病以及慢性肾小球肾炎(CGN)在非裔美国人中更为常见。为了探究遗传因素是否可能在非裔美国人ESRD风险增加中起作用,将131名接受血液透析的非裔美国患者(病例)的家族史与115名年龄、性别和种族匹配的非ESRD对照进行了比较。计算优势比(OR)以确定病例组与对照组中患有ESRD亲属的患病率。从对数线性模型估计卡方值,同时控制性别,以检验OR的显著性。40%(12/30)的HN病例、35%(18/51)的II型糖尿病所致肾衰竭病例和13%(5/38)的CGN病例有一级、二级或三级亲属患有ESRD。有ESRD一级亲属会使非裔美国人患ESRD的风险增加9倍(OR,9.13;95%置信区间[CI],2.6至31.8;P < 0.001)。有一级或二级亲属会使风险增加5倍(OR,5.23;95%CI,2.2至12.3;P < 0.0002)。与CGN相比,ESRD一级、二级或三级亲属在因高血压和II型糖尿病导致ESRD的病例中更为常见(P≤0.05)。OR中的性别差异不显著(P > 0.2),病例组和对照组之间的社会经济阶层(教育水平和收入)没有明显差异。(摘要截选至250字)

相似文献

1
The familial risk of end-stage renal disease in African Americans.非裔美国人终末期肾病的家族风险。
Am J Kidney Dis. 1993 Apr;21(4):387-93. doi: 10.1016/s0272-6386(12)80266-6.
2
Familial predisposition to nephropathy in African-Americans with non-insulin-dependent diabetes mellitus.非胰岛素依赖型糖尿病的非裔美国人患肾病的家族易感性。
Am J Kidney Dis. 1995 May;25(5):710-3. doi: 10.1016/0272-6386(95)90546-4.
3
Familial risk, age at onset, and cause of end-stage renal disease in white Americans.
J Am Soc Nephrol. 1995 Apr;5(10):1806-10. doi: 10.1681/ASN.V5101806.
4
Familial clustering of end-stage renal disease in blacks with lupus nephritis.狼疮性肾炎黑人患者终末期肾病的家族聚集性。
Am J Kidney Dis. 1997 May;29(5):729-32. doi: 10.1016/s0272-6386(97)90126-8.
5
Kidney disease in the first-degree relatives of African-Americans with hypertensive end-stage renal disease.患有高血压终末期肾病的非裔美国人一级亲属中的肾脏疾病。
Am J Kidney Dis. 1996 Mar;27(3):341-6. doi: 10.1016/s0272-6386(96)90356-x.
6
Familial clustering of end-stage renal disease in Mississippi.密西西比州终末期肾病的家族聚集性。
J Miss State Med Assoc. 2002 Mar;43(3):71-7.
7
Genetic linkage analysis of growth factor loci and end-stage renal disease in African Americans.非裔美国人中生长因子基因座与终末期肾病的遗传连锁分析。
Kidney Int. 1997 Mar;51(3):819-25. doi: 10.1038/ki.1997.115.
8
Inaccuracy of clinical phenotyping parameters for hypertensive nephrosclerosis.高血压性肾硬化临床表型参数的不准确性。
Nephrol Dial Transplant. 2000 Nov;15(11):1801-7. doi: 10.1093/ndt/15.11.1801.
9
Association of APOL1 variants with mild kidney disease in the first-degree relatives of African American patients with non-diabetic end-stage renal disease.APOL1 变异与非糖尿病终末期肾病的非裔美国患者一级亲属中轻度肾脏疾病的关联。
Kidney Int. 2012 Oct;82(7):805-11. doi: 10.1038/ki.2012.217. Epub 2012 Jun 13.
10
Familial clustering of end-stage renal disease in blacks with HIV-associated nephropathy.HIV相关性肾病黑人患者终末期肾病的家族聚集性。
Am J Kidney Dis. 1999 Aug;34(2):254-8. doi: 10.1016/s0272-6386(99)70352-5.

引用本文的文献

1
APOL1 Dynamics in Diabetic Kidney Disease and Hypertension.载脂蛋白L1在糖尿病肾病和高血压中的动态变化
Biomolecules. 2025 Feb 1;15(2):205. doi: 10.3390/biom15020205.
2
A pragmatic approach to selective genetic testing in kidney transplant candidates.肾移植候选者选择性基因检测的实用方法。
Front Transplant. 2024 Jan 16;2:1342471. doi: 10.3389/frtra.2023.1342471. eCollection 2023.
3
The Minnesota attributable risk of kidney donation (MARKD) study: a retrospective cohort study of long-term (> 50 year) outcomes after kidney donation compared to well-matched healthy controls.
明尼苏达州可归因于肾脏捐献的风险(MARKD)研究:一项回顾性队列研究,比较了长期(>50 年)肾脏捐献后与匹配良好的健康对照者的长期结果。
BMC Nephrol. 2023 May 1;24(1):121. doi: 10.1186/s12882-023-03149-7.
4
Association between human leukocyte antigen (HLA) and end-stage renal disease (ESRD): a meta-analysis.人类白细胞抗原(HLA)与终末期肾病(ESRD)的关联:一项荟萃分析。
PeerJ. 2023 Feb 13;11:e14792. doi: 10.7717/peerj.14792. eCollection 2023.
5
Identification of genetic variants associated with diabetic kidney disease in multiple Korean cohorts via a genome-wide association study mega-analysis.通过全基因组关联研究荟萃分析鉴定多个韩国队列中与糖尿病肾病相关的遗传变异。
BMC Med. 2023 Jan 11;21(1):16. doi: 10.1186/s12916-022-02723-4.
6
Evaluation of Genetic Kidney Diseases in Living Donor Kidney Transplantation: Towards Precision Genomic Medicine in Donor Risk Assessment.活体供肾移植中遗传性肾脏疾病的评估:迈向供体风险评估中的精准基因组医学
Curr Transplant Rep. 2022 Jun;9(2):127-142. doi: 10.1007/s40472-021-00340-3. Epub 2022 Mar 16.
7
Approach to genetic testing to optimize the safety of living donor transplantation in Alport syndrome spectrum.针对 Alport 综合征谱中活体供者移植安全性的遗传检测方法。
Pediatr Nephrol. 2022 Sep;37(9):1981-1994. doi: 10.1007/s00467-022-05430-7. Epub 2022 Jan 27.
8
Familial Contributions to the Association Between Low Birth Weight and Risk of CKD in Adult Life.家族因素对低出生体重与成年期慢性肾脏病风险之间关联的影响。
Kidney Int Rep. 2021 May 30;6(8):2151-2158. doi: 10.1016/j.ekir.2021.05.032. eCollection 2021 Aug.
9
Gender Differences in Diabetic Kidney Disease: Focus on Hormonal, Genetic and Clinical Factors.性别差异与糖尿病肾病:关注激素、遗传和临床因素。
Int J Mol Sci. 2021 May 28;22(11):5808. doi: 10.3390/ijms22115808.
10
APOL1 at 10 years: progress and next steps.APOL1 研究 10 年:进展与未来方向
Kidney Int. 2021 Jun;99(6):1296-1302. doi: 10.1016/j.kint.2021.03.013. Epub 2021 Mar 29.